Overview Valtoco is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat episodes of frequent seizure activity in adults and children ages 2 and older. These episodes follow a recognizable pattern and differ from a person’s usual seizure pattern.

How do I take it?

Prescribing information states that Valtoco is intended for intranasal use only. Health care professionals should instruct the individuals giving the nasal spray when and how to use it appropriately.

Side effects

The FDA-approved label for Valtoco lists common side effects including drowsiness, headache, and nasal discomfort. Rare but serious side effects listed for Valtoco include central nervous system depression, suicidal behavior and ideation, glaucoma, depression, slurred speech, syncope (loss of consciousness), changes in libido, urinary retention, bradycardia (slow heartrate), cardiovascular collapse (loss of consciousness due to heart dysfunction), nystagmus (quick uncontrollable eye movements), urticaria (allergic skin rash), neutropenia (low level of white blood cells called neutrophils), and jaundice (yellowing of the skin). Valtoco carries a warning that taking medications in this class (benzodiazepines) with opioid medicines, alcohol, or other central nervous system depressants can cause severe drowsiness, breathing problems, coma, and death.

For more details about this treatment, visit:

Valtoco — Neurelis www.valtoco.com

Valtoco (Diazepam Nasal Spray) for the Acute Treatment of Intermittent Stereotypic Episodes of Frequent Seizure Activity — Neurology International www.ncbi.nlm.nih.gov/pmc/articles/PMC7931041/